List of Publicly Traded Companies Focusing on Gastrointestinal Disorders Listed on Major U.S. Exchanges

The publicly traded companies on this list are biotech, medical device, pharmaceutical or other healthcare companies that provide products and treatments relating to gastrointestinal conditions. It is very common for companies on this list to provide products and services in other healthcare areas in addition to gastrointestinal conditions.

Additional publicly traded healthcare companies and healthcare categories can be accessed through the link below:

List of Publicly Traded Healthcare Companies

A comparison widget that shows trend, earnings per share (EPS), P/E ratio and beta for each of the companies on this list can be accessed through the link below.

Gastrointestinal Disorders Industry Comparison Widget

Select the company’s link to access charts, news links and company website and social media information.

Gastrointestinal: Large-Cap Stocks

Abbott Laboratories (ABT) (Nutritional products; medical devices, diagnostics, pharmaceuticals: generic pharmaceuticals gastroenterology products, women’s health products, cardiovascular and metabolic, pain and nervous system, respirtaroy drugs, vaccines; vascular products)

Allergan, Inc. (AGN) (Generics, biosimilars, dermatology and aesthetics, central nervous system, eye care, women’s health and urology, GI and cystic fibrosis, cardiovascular and infectious disease)

Boston Scientific Corporation (BSX) (Areas of focus include digestive, heart, pulmonary, urological, vascular, women’s health)

Gastrointestinal: Mid-Cap Stocks

Ironwood Pharmaceuticals, Inc. (IRWD) (Gastrointestinal disorders)

Gastrointestinal: Small-Cap Stocks

Ardelyx, Inc. (ARDX) (Molecule therapeutics: gastrointestinal)

Halyard Health, Inc. (HYH) (Medical technology company: areas of focus include Infection prevention products, pain management, respiratory, wound management and digestive health)

Motus GI Holdings, Inc. (MOTS) (IPO February 14, 2018; medical device company)

Quidel Corporation (QDEL) (Tests for infectious diseases, gastrointestinal diseases and women’s health)

Seres Therapeutics Inc. (MCRB) (IPO in June 2015: microbiome therapeutics platform)

Synergy Pharmaceuticals, Inc. (SGYP) (Biopharmaceutical company: therapies for the treatment of gastrointestinal diseases and disorders)

Theravance Biopharma, Inc. (TBPH) (Biopharmaceutical company: diseases of the lung, gastrointestinal tract, infectious diseases)

Zealand Pharma A/S (ZEAL) (IPO August 9, 2017; biotechnology company: gastrointestinal and metabolic diseases)

Gastrointestinal: Micro-Cap Stocks

Redhill Biopharma Ltd. (RDHL) (Israel, biopharmaceutical company: inflammatory and gastrointestinal diseases, gastrointestinal cancers)

Gastrointestinal: Nano-Cap Stocks

AzurRx BioPharma, Inc. (AZRX) (IPO October 11, 2016: Development stage biopharmaceutical company focused on gastrointestinal disorders)

Evoke Pharma, Inc. (EVOK) (Drugs to treat gastrointestinal disorders and diseases)

Ritter Pharmaceuticals Inc. (RTTR) (IPO in June 2015: Specialty pharmaceutical company: gastrointestinal diseases)

Related Links:

Publicly Traded Companies by Sector and Industry

List of Healthcare Companies

List of Pharmaceutical Companies

List of Biotech Companies